4//SEC Filing
VANLENT ANNE 4
Accession 0000899243-19-013251
CIK 0001563880other
Filed
May 12, 8:00 PM ET
Accepted
May 13, 5:00 PM ET
Size
11.1 KB
Accession
0000899243-19-013251
Insider Transaction Report
Form 4
VANLENT ANNE
Director
Transactions
- Conversion
Common Stock
2019-05-09+20,983→ 20,983 total - Conversion
Series C Preferred Stock
2019-05-09−47,807→ 0 total→ Common Stock (5,582 underlying) - Purchase
Common Stock
2019-05-09$10.00/sh+5,000$50,000→ 25,983 total - Conversion
Series A Preferred Stock
2019-05-09−107,977→ 0 total→ Common Stock (15,401 underlying)
Footnotes (2)
- [F1]On May 9, 2019, the Series A Preferred Stock, and the dividends that had accrued thereon to date, converted into Common Stock on a 9.5-for-one basis without payment of further consideration automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.
- [F2]On May 9, 2019, the Series C Preferred Stock, and the dividends that had accrued thereon to date, converted into Common Stock on a 9.5-for-one basis without payment of further consideration automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.
Documents
Issuer
Trevi Therapeutics, Inc.
CIK 0001563880
Entity typeother
Related Parties
1- filerCIK 0001229243
Filing Metadata
- Form type
- 4
- Filed
- May 12, 8:00 PM ET
- Accepted
- May 13, 5:00 PM ET
- Size
- 11.1 KB